Evidence map›Paper›PMID 29566084›Full record

ArticlePloS one2018

Next-generation sequencing analysis of a cluster of hepatitis C virus infections in a haematology and oncology center.

Kamila Caraballo Cortes, Magdalena Rosińska, Maciej Janiak, Małgorzata Stępień, Osvaldo Zagordi, Karol Perlejewski, Sylwia Osuch, Agnieszka Pawełczyk, Iwona Bukowska-Ośko, Rafał Płoski and 3 more

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kamila Caraballo CortesDepartment of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0002-7924-7852
Magdalena RosińskaNational Institute of Public Health-National Institute of Hygiene (NIPH-NIH), Warsaw, Poland.
Maciej JaniakDepartment of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.
Małgorzata StępieńNational Institute of Public Health-National Institute of Hygiene (NIPH-NIH), Warsaw, Poland.
Osvaldo ZagordiInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Karol PerlejewskiDepartment of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.
Sylwia OsuchDepartment of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.
Agnieszka PawełczykDepartment of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.
Iwona Bukowska-OśkoDepartment of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.
Rafał PłoskiDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Piotr GrabarczykDepartment of Virology, Institute of Hematology and Transfusiology, Warsaw, Poland.
Tomasz LaskusDepartment of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.
Marek RadkowskiDepartment of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular characterization of early hepatitis C virus (HCV) infection remains rare. Ten out of 78 patients of a hematology/oncology center were found to be HCV RNA positive two to four months after hospitalization. Only two of the ten patients were anti-HCV positive. HCV hypervariable region 1 (HVR1) was amplified in seven patients (including one anti-HCV positive) and analyzed by next generation sequencing (NGS). Genetic variants were reconstructed by Shorah and an empirically established 0.5% variant frequency cut-off was implemented. These sequences were compared by phylogenetic and diversity analyses. Ten unrelated blood donors with newly acquired HCV infection detected at the time of donation (HCV RNA positive and anti-HCV negative) served as controls. One to seven HVR1 variants were found in each patient. Sequences intermixed phylogenetically with no evidence of clustering in individual patients. These sequences were more similar to each other (similarity 95.4% to 100.0%) than to those of controls (similarity 64.8% to 82.6%). An identical predominant variant was present in four patients, whereas other closely related variants dominated in the remaining three patients. In five patients the HCV population was limited to a single variant or one predominant variant and minor variants of less than 10% frequency. In conclusion, NGS analysis of a cluster of HCV infections acquired in the hospital setting revealed the presence of low diversity, very closely related variants in all patients, suggesting an early-stage infection with the same virus. NGS combined with phylogenetic analysis and classical epidemiological analysis could help in tracking of HCV outbreaks.

Indexed as

Cancer Care FacilitiesHigh-Throughput Nucleotide SequencingAdultAgedAged, 80 and overCase-Control StudiesCluster AnalysisDisease OutbreaksFemaleGenetic VariationHematologyHepacivirusHepatitis CHospitals, SpecialHumansMaleRNA, Viral

Identifiers

PMID29566084
PMCPMC5864040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.